Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma

被引：0
|
作者：
Cerchione, Claudio [1 ]
Martinelli, Giovanni [2 ]
Nappi, Davide [3 ]
Pareto, Anna Emanuele [3 ]
Di Perna, Maria [3 ]
Ronconi, Sonia [4 ]
Pane, Fabrizio [3 ]
Catalano, Lucio [5 ]
机构：
[1] IRCCS, IRST, Meldola, FC, Italy
[2] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori IRST, Hematol Unit, Meldola, FC, Italy
[3] AOU Federico II, Naples, Italy
[4] European Myeloma Network Italy, GIMEMA, Meldola, Italy
[5] AOU Federico II, GIMEMA, Naples, Italy
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
Heavily pretreated; Pomalidomide; Real-World Data;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-309
引用
收藏
页码：E359 / E359
页数：1
相关论文
共 50 条
  • [21] Pegfilgrastim versus filgrastim in the supportive care of heavily pretreated multiple myeloma in treatment with pomalidomide-dexamethasone
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Musuraca, Gearardo
    Ronconi, Sonia
    Cangini, Delia
    Ceccolini, Michela
    Marchesini, Matteo
    Pane, Fabrizio
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S136 - S136
  • [22] DOMESTIC OPPORTUNITY IN HEAVILY PRETREATED MULTIPLE MYELOMA NOT ELIGIBLE TO HOSPITAL-BASED TREATMENT: ROLE OF POMALIDOMIDE-DEXAMETHASONE
    Cerchione, C.
    Catalano, L.
    Nappi, D.
    Pareto, A. E.
    Musuraca, G.
    Lucchesi, A.
    Ronconi, S.
    Ceccolini, M.
    Cangini, D.
    Pane, F.
    Martinelli, G.
    HAEMATOLOGICA, 2022, 107 : 86 - 87
  • [23] HIGH RISK MULTIPLE MYELOMA IN RELAPSE: RESPONSE TO TREATMENT WITH POMALIDOMIDE-DEXAMETHASONE
    Gil, A.
    De Miguel, D.
    D, Subira
    H, Guillen
    A, Vazquez
    Arbeteta, J.
    Herrero, S.
    Morales, M. D.
    Golbano, N.
    Perez, A.
    A, Martin
    Pinedo, A.
    HAEMATOLOGICA, 2017, 102 : 98 - 99
  • [24] PEGFILGRASTIM VERSUS FILGRASTIM IN THE SUPPORTIVE CARE OF HEAVILY PRE-TREATED MULTIPLE MYELOMA IN TREATMENT WITH POMALIDOMIDE-DEXAMETHASONE
    Cerchione, C.
    Martinelli, G.
    Nappi, D.
    Pareto, A. E.
    Lucchesi, A.
    Musuraca, G.
    Ronconi, S.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2019, 104 : 148 - 148
  • [25] Pomalidomide-dexamethasone combination is efficient in lenalidomide-refractory multiple myeloma
    Coman, Tereza
    HEMATOLOGIE, 2010, 16 (06): : 410 - 411
  • [26] Pomalidomide in heavily pretreated refractory multiple myeloma: a case report
    Palmas, Angelo
    Piras, Giovanna
    Uras, Antonella
    Asproni, Rosanna
    Murineddu, Marco
    Monne, Maria
    Stradoni, Roberta
    Latte, Giancarlo
    FUTURE ONCOLOGY, 2017, 13 (05) : 7 - 9
  • [27] Pegfilgrastim versus filgrastim in the supportive care of heavily pretreated multiple myeloma in treatment with pomalidomide-dexamethasone.
    Cerchione, Claudio
    Martinelli, Giovanni
    Nappi, Davide
    Pareto, Anna Emanuele
    Musuraca, Gerardo
    Lucchesi, Alessandro
    Pane, Fabrizio
    Catalano, Lucio
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Pegfilgrastim vs. Filgrastim in the Supportive Care of Heavily Pre-Treated Multiple Myeloma in Treatment with Pomalidomide-Dexamethasone
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Pareto, Anna Emanuele
    Musuraca, Gerardo
    Lucchesi, Alessandro
    Pane, Fabrizio
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S311 - S312
  • [29] Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
    Richardson, Paul G.
    Perrot, Aurore
    San Miguel, Jesus
    Beksac, Meral
    Spicka, Ivan
    Leleu, Xavier
    Schjesvold, Fredrik
    Moreau, Philippe
    Dimopoulos, Meletios A.
    Huang, Shang-Yi
    Minarik, Jiri
    Cavo, Michele
    Prince, H. Miles
    Mace, Sandrine
    Zhang, Rick
    Dubin, Franck
    Morisse, Mony Chenda
    Anderson, Kenneth C.
    HAEMATOLOGICA, 2024, 109 (07) : 2239 - 2249
  • [30] Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
    Richardson, Paul G.
    Perrot, Aurore
    San Miguel, Jesus
    Beksac, Meral
    Spicka, Ivan
    Leleu, Xavier
    Schjesvold, Fredrik
    Moreau, Philippe
    Dimopoulos, Meletios A.
    Huang, Shang-Yi
    Minarik, Jiri
    Cavo, Michele
    Prince, H. Miles
    Mace, Sandrine
    Zhang, Rick
    Dubin, Franck
    Morisse, Mony Chenda
    Anderson, Kenneth C.
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 2239 - 2249
12345